HEPATITIS B NUCLEOCAPSID PARTICLE AS IMMUNOPOTENTIATOR OF INNATE AND ADAPTIVE IMMUNITY FOR NASAL VACCINES CIGB 2020 AND MAMBISA AGAINST COVID-19

HEPATITIS B NUCLEOCAPSID PARTICLE AS IMMUNOPOTENTIATOR OF INNATE AND ADAPTIVE IMMUNITY FOR NASAL VACCINES CIGB 2020 AND MAMBISA AGAINST COVID-19

Intro: The concept of training immunity originally developed for other diseases has gained attraction during the epidemic. Several clinical trials and epidemiological analyses of populations previously immunized with BCG and other vaccines were the focus of scientific discussions. Here we show the a...

Full description

Bibliographic Details
Main Authors: G. Guillen, M. Limonta, V. Muzio, Z. Cinza, G. Lemos, G. Chinea, A. Martin, D. Gonzalez-Roche, I. Valdes, Y. Mendosa, J. Aguiar, M. Bequet, G. Marques, J. Zamora, E. Penton, E. Iglesias, J. Aguilar, O. Cruz, M. Ayala, E. Pimentel, E. Martinez
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223001583

Internet

http://www.sciencedirect.com/science/article/pii/S1201971223001583

Similar Items